ATE429504T1 - Proteinexpressionsvektor und benutzung desselbigen - Google Patents

Proteinexpressionsvektor und benutzung desselbigen

Info

Publication number
ATE429504T1
ATE429504T1 AT99972690T AT99972690T ATE429504T1 AT E429504 T1 ATE429504 T1 AT E429504T1 AT 99972690 T AT99972690 T AT 99972690T AT 99972690 T AT99972690 T AT 99972690T AT E429504 T1 ATE429504 T1 AT E429504T1
Authority
AT
Austria
Prior art keywords
expression vector
nucleotide sequence
protein expression
downstream side
cloning site
Prior art date
Application number
AT99972690T
Other languages
English (en)
Inventor
Hidetoshi Uemura
Akira Okui
Katsuya Kominami
Nozomi - Yamaguchi
Shinichi Mitsui
Original Assignee
Fuso Pharmaceutical Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuso Pharmaceutical Ind filed Critical Fuso Pharmaceutical Ind
Application granted granted Critical
Publication of ATE429504T1 publication Critical patent/ATE429504T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6445—Kallikreins (3.4.21.34; 3.4.21.35)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT99972690T 1998-11-20 1999-11-19 Proteinexpressionsvektor und benutzung desselbigen ATE429504T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP33151598 1998-11-20
PCT/JP1999/006474 WO2000031284A1 (en) 1998-11-20 1999-11-19 Protein expression vector and utilization thereof

Publications (1)

Publication Number Publication Date
ATE429504T1 true ATE429504T1 (de) 2009-05-15

Family

ID=18244518

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99972690T ATE429504T1 (de) 1998-11-20 1999-11-19 Proteinexpressionsvektor und benutzung desselbigen

Country Status (8)

Country Link
US (1) US7029909B1 (de)
EP (1) EP1132479B1 (de)
JP (1) JP4475814B2 (de)
AT (1) ATE429504T1 (de)
AU (1) AU765111B2 (de)
CA (1) CA2350226C (de)
DE (1) DE69940785D1 (de)
WO (1) WO2000031284A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002061064A2 (de) * 2001-02-01 2002-08-08 Roche Diagnostics Gmbh Verfahren zur herstellung von rekombinantem trypsin
AU2002350039A1 (en) 2001-10-29 2003-05-12 Renovis, Inc. Method for isolating cell-type specific mrnas
PL195457B1 (pl) * 2002-08-05 2007-09-28 Zaklady Farm Polpharma Sa Kaseta ekspresyjna, dwucistronowy wektor plazmidowy, środek farmaceutyczny oraz ich zastosowanie
JP2006345831A (ja) * 2005-06-20 2006-12-28 P-Lap:Kk Ｄｎａ、ベクター、形質転換体、及びａｐａタンパク質の製造方法
JP5130662B2 (ja) * 2006-06-07 2013-01-30 Ｊｎｃ株式会社 タンパク質の可溶性タンパク質としての製造方法
WO2008051383A2 (en) * 2006-10-19 2008-05-02 Amgen Inc. Use of alcohol co-solvents to improve pegylation reaction yields
AR063384A1 (es) 2006-10-25 2009-01-28 Amgen Inc Agentes terapeuticos a base de peptidos derivados de toxinas
EP2738257A1 (de) 2007-05-22 2014-06-04 Amgen Inc. Zusammensetzungen und Verfahren zur Herstellung bioaktiver Fusionsproteine
WO2009114185A2 (en) 2008-03-12 2009-09-17 The Rockefeller University Methods and compositions for translational profiling and molecular phenotyping
EP3385279B1 (de) 2009-03-20 2020-02-26 Amgen Inc. Träger-immunglobuline und verwendungen davon
AU2010321832B2 (en) 2009-11-20 2014-08-14 Amgen Inc. Anti-Orai1 antigen binding proteins and uses thereof
JP2013535692A (ja) 2010-08-10 2013-09-12 アムジエン・インコーポレーテツド 標的抗体に対する中和抗体検出用インビトロ二重機能標的結合アッセイ
EP2619226B1 (de) 2010-09-22 2018-09-12 Amgen Inc. Träger-immunglobuline und verwendungen davon
CN105821078A (zh) * 2010-12-09 2016-08-03 巴斯德研究所 用于获得高产量重组蛋白表达的基于mgmt的方法
JP2014507136A (ja) 2011-01-18 2014-03-27 アムジエン・インコーポレーテツド ＮａＶ１．７ノックアウトマウスとそれらの使用
US9340590B2 (en) 2011-03-16 2016-05-17 Amgen Inc. Potent and selective inhibitors of NaV1.3 and NaV1.7
US20150201588A1 (en) 2012-02-22 2015-07-23 Amgen Inc. Autologous Mammalian Models Derived from Induced Pluripotent Stem Cells and Related Methods
WO2013177533A1 (en) * 2012-05-25 2013-11-28 California Institute Of Technology Expression of secreted and cell-surface polypeptides
WO2014165277A2 (en) 2013-03-12 2014-10-09 Amgen Inc. POTENT AND SELECTIVE INHIBITORS OF Nav1.7
US11078464B2 (en) 2013-08-30 2021-08-03 Amgen Inc. High titer recombinant AAV vector production in adherent and suspension cells
US9822156B2 (en) 2014-06-13 2017-11-21 Whitehead Institute For Biomedical Research Amyloid beta expression constructs and uses therefor
WO2016061141A1 (en) 2014-10-13 2016-04-21 University Of Maryland, Baltimore Methods for treating cardiovascular dysfunction and improving fluid homeostasis with a peptide hormone
EP3207146B1 (de) 2014-10-15 2021-09-29 Amgen Inc. Promotor und regulatorische elemente zur verbesserten expression von heterologen genen in wirtszellen
KR101787485B1 (ko) * 2015-12-30 2017-11-15 재단법인 의약바이오컨버젼스연구단 재조합 picp 단백질 및 이에 특이적으로 결합하는 항체의 제조방법
WO2017132376A1 (en) 2016-01-27 2017-08-03 Just Biotherapeutics, Inc. Hybrid promoter and uses thereof
CA3043487A1 (en) 2016-11-21 2018-05-24 Just-Evotec Biologics Inc Aflibercept formulations and uses thereof
ES2887046T3 (es) 2017-08-17 2021-12-21 Just Evotec Biologics Inc Método de purificación de proteína glicosilada a partir de galectinas de las células hospedadoras y otros contaminantes
WO2019099965A1 (en) 2017-11-20 2019-05-23 Just Biotherapeutics, Inc. Aflibercept formulations containing a lysine salt as tonicifying agent and uses thereof
EP3924458A1 (de) 2019-02-15 2021-12-22 Just-Evotec Biologics, Inc. Automatisierte bioherstellungssysteme, anlagen und prozesse
WO2023287707A1 (en) 2021-07-15 2023-01-19 Just-Evotec Biologics, Inc. Bidirectional tangential flow filtration (tff) perfusion system
CA3251731A1 (en) 2022-02-10 2023-08-17 Amgen Inc. ANTIBODY PROTEIN PROTEIN EXPRESSION CONSTRUCTIONS FOR HIGH-THROUGH SEQUENCING
CA3266599A1 (en) 2022-09-07 2024-11-07 Quantitative Biosciences, Inc. UNIQUE VARIABLE DOMAIN ANTIBODIES SPECIFIC TO FENTANYL AND USE IN A CONTINUOUS AGGLUTINATION TEST
WO2025128343A1 (en) 2023-12-11 2025-06-19 Just-Evotec Biologics, Inc. Protein expression using trans-splicing and split selectable markers
CN118580307B (zh) * 2024-05-21 2025-05-27 广东合鸣生物科技有限公司 一种具备紧致抗皱功效的Pro.AH8乙酰基六肽-8及其制备方法和应用
CN121320399B (zh) * 2025-12-15 2026-05-05 江苏省中国科学院植物研究所 用于高产ghk的重组载体、重组菌及发酵方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3582965B2 (ja) * 1996-08-23 2004-10-27 株式会社イムノ・ジャパン 哺乳動物細胞用発現ベクター

Also Published As

Publication number Publication date
AU1184000A (en) 2000-06-13
JP4475814B2 (ja) 2010-06-09
EP1132479A1 (de) 2001-09-12
DE69940785D1 (de) 2009-06-04
AU765111B2 (en) 2003-09-11
EP1132479B1 (de) 2009-04-22
EP1132479A4 (de) 2005-08-10
WO2000031284A1 (en) 2000-06-02
US7029909B1 (en) 2006-04-18
CA2350226A1 (en) 2000-06-02
CA2350226C (en) 2012-04-24

Similar Documents

Publication Publication Date Title
DE69940785D1 (de) Proteinexpressionsvektor und benutzung desselbigen
BRPI9912663B1 (pt) vacina contra cáncer e polipeptìdeo.
NO20034959L (no) Anti-frys konsentrat inneholdende fargestoffer C.I. reactive violet 5
ATE347599T1 (de) Tuberkulose impfstoff
WO1999003881A3 (fr) Polypeptide chimerique comprenant le fragment b de la toxine shiga et des peptides d'interet therapeutique
CY1106978T1 (el) Ενζυμα φωσφοδιεστερασης
IT1268332B1 (it) Dispositivo manipolatore per la movimentazione, in particolare per l'orientamento di pezzi, utensili, o simili.
ATE348158T1 (de) Neuartiges collectin
DK0919621T3 (da) Human TAK1 og DNA der koder derfor
EA200000567A1 (ru) Бактериальные плазмиды
ATE307940T1 (de) Putzleiste aus kunststoff
NO981707L (no) Xylanase, oligonukleotidsekvens som koder for xylanase og anvendelse derav
DE69421665D1 (de) Anomere Fluorribosylamine
DE69731682D1 (de) TAB1 Protein und dafür kodierende DNA
ITTO20010545A0 (it) Apparecchiatura di controllo dell'iniezione di carburante.
NO20011961D0 (no) PRV-1-genet og anvendelsen av dette
FR2710113B1 (fr) Barreau magnétique courbe ou rectiligne, formé d'aimants disjoints.
DE69930370D1 (de) Testisspezifische, menschliche proteinase, svph1-8
Deutsch et al. Erratum: Interaction Physics of the Fast Ignitor Concept [Phys. Rev. Lett. 77, 2483 (1996)]
NL1012028A1 (nl) Aminozuursequentie.
DE69831584T2 (de) Polypeptide mit wasserkanalaktivität und dna sequenzen
ATE409747T1 (de) Mit wt1 interagierendes protein, wtip
Hollander Above the Glass Ceiling
ITTO20010544A0 (it) Apparecchiatura di controllo dell'iniezione di carburante.
ES1024828Y (es) Sujeta corbatas.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties